CYP3A5 polymorphism in kidney transplantation: individualizing tacrolimus dosing

被引：0
|
作者：
Pasari, Amit S. [1 ,2 ]
Balwani, Manish R. [1 ,2 ]
Bawankule, Charulata [1 ,2 ]
Sejpal, Kapil [1 ]
Gurjar, Prasad [1 ]
Kashiv, Pranjal [1 ]
Dubey, Shubham [1 ]
Malde, Sunny [1 ]
Gupta, Sushrut [1 ]
Pawar, Twinkle [1 ]
机构：
[1] JNMC, Nephrol, Wardha, India
[2] Saraswati Kidney Care Ctr, Nephrol, Nagpur, Maharashtra, India
来源：
TRANSPLANTATION | 2024年 / 108卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
302.4
引用
收藏
页码：170 / 170
页数：1
相关论文
共 50 条
  • [1] Tacrolimus and Diabetes in Kidney Transplantation: The Impact of Cyp3a5 Gene Polymorphism
    Liang, Siyu
    Zhu, Xiaoqiu
    Cai, Ruiming
    Yan, Baomei
    Liang, Weixiang
    Cai, Mingjin
    Yang, Pengfeng
    [J]. TRANSPLANTATION PROCEEDINGS, 2023, 55 (10) : 2398 - 2402
  • [2] Effect of CYP3A5*1/*3 polymorphism in Tacrolimus dose requirements in kidney transplantation
    Montes Ares, Olga
    Guerra Rodriguez, Rita
    Torio Ruiz, Alberto
    Fernandez Tagarro, Ernesto
    Gonzalez Henriquez, Maria Isabel
    Perez Valentin, Miguel Angel
    Trejo Benitez, Maria Ceferina
    Dolores Checa de Andres, Maria
    [J]. TISSUE ANTIGENS, 2010, 75 (05): : 605 - 605
  • [3] Effects of tacrolimus intrapatient variability and CYP3A5 polymorphism on the outcomes of pediatric kidney transplantation
    Choi, Jin Sun
    Ko, Hyunmin
    Kim, Hyo Kee
    Chung, Chris
    Han, Ahram
    Min, Seung-Kee
    Ha, Jongwon
    Kang, Hee Gyung
    Ha, Il Soo
    Min, Sangil
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26 (06)
  • [4] Tacrolimus pharmacokinetics and pharmacodynamics in kidney transplantation: The role of CYP3A5 polymorphism in a pediatric population
    Ghio, L.
    Ferraresso, M.
    Tirelli, S.
    Grillo, P.
    Belingheri, M.
    Martina, V.
    Torresani, E.
    Edefonti, A.
    [J]. PEDIATRIC NEPHROLOGY, 2007, 22 (09) : 1588 - 1588
  • [5] Impact of Tacrolimus Intraindividual Variability and CYP3A5 Genetic Polymorphism on Acute Rejection in Kidney Transplantation
    Ro, Han
    Min, Sang-Il
    Yang, Jaeseok
    Moon, Kyung Chul
    Kim, Yon Su
    Kim, Sang Joon
    Ahn, Curie
    Ha, Jongwon
    [J]. THERAPEUTIC DRUG MONITORING, 2012, 34 (06) : 680 - 685
  • [6] Impact of CYP3A5 genotype on de-novo LCP tacrolimus dosing and monitoring in kidney transplantation
    Rao, Nikhil
    Carcella, Taylor
    Patel, Neha
    Bartlett, Felicia
    Posadas, Maria Aurora
    Casey, Michael
    Dubay, Derek A.
    Taber, David J.
    [J]. PHARMACOGENETICS AND GENOMICS, 2023, 33 (03): : 59 - 65
  • [7] CYP3A5 Polymorphism in Mexican Renal Transplant Recipients and its Association with Tacrolimus Dosing
    Garcia-Roca, Pilar
    Medeiros, Mara
    Reyes, Herlinda
    Antonio Rodriguez-Espino, Benjamin
    Alberu, Josefina
    Ortiz, Lourdes
    Vasquez-Perdomo, Mayela
    Elizondo, Guillermo
    Eduardo Morales-Buenrostro, Luis
    Mancilla Urrea, Eduardo
    Castaneda-Hernandez, Gilberto
    [J]. ARCHIVES OF MEDICAL RESEARCH, 2012, 43 (04) : 283 - 287
  • [8] EFFECTS OF CYP3A5 POLYMORPHISM AND INTRA-PATIENT TACROLIMUS VARIABILITY ON KIDNEY ALLOGRAFT SURVIVAL AFTER KIDNEY TRANSPLANTATION
    Sasisakulporn, Jaruwit
    Phakdeekitcharoen, Bunyong
    Kantachuvesiri, Surasak
    Sumethkul, Vasant
    Kitiyakara, Chagriya
    Disthabanchong, Sinee
    Nongnuch, Arkom
    Wiwattanathum, Punlop
    Ingsathit, Atiporn
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 62 - 62
  • [9] Tacrolimus dose requirement in pediatric liver transplantation: influence of CYP3A5 gene polymorphism
    Durand, Philippe
    Debray, Dominique
    Kolaci, Mikaela
    Bouligand, Jerome
    Furlan, Valerie
    Fabre, Monique
    Letierce, Alexia
    Verstuyft, Celine
    Becquemont, Laurent
    [J]. PHARMACOGENOMICS, 2013, 14 (09) : 1017 - 1025
  • [10] Impact of CYP3A5 polymorphism on trough concentrations and outcomes of tacrolimus minimization during the early period after kidney transplantation
    Yaowakulpatana, Khemjira
    Vadcharavivad, Somratai
    Ingsathit, Atiporn
    Areepium, Nutthada
    Kantachuvesiri, Surasak
    Phakdeekitcharoen, Bunyong
    Sukasem, Chonlaphat
    Sra-ium, Supasil
    Sumethkul, Vasant
    Kitiyakara, Chagriya
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (03) : 277 - 283
12345